Subject: MJNA Gets Product Validation PZOO Adds Another Retailer

SCV Client Spotlight
MJNA Gets Product Validation PZOO Adds Another Retailer
Top PerformerYesterday's Top Performer

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

End of Day:

Price: 0.06

Change (%): + 0.004 (7.14)

Volume: 1,747,262
MJNA Chart

Medical Marijuana Inc. Announces Dixie X Compassionate Care Club

SAN DIEGO, Sept. 19, 2012 /PRNewswire/ - Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce the Compassionate Care Club, a customer loyalty program for its Dixie X line, launched by portfolio company Red Dice Holdings.

Since the beginning of sales of Dixie X, in June of this year, thousands of customers have purchased the non-THC, Hemp-derived CBD health and wellness products. Available in 100 or 500-milligram Dixie X CBD Dew Drops, Dixie X CBD Salve and 25 milligram Dixie X CBD Scrips capsules, these revolutionary products have been developed using Hemp-based high concentrate CBD oil. Cannabidiol or CBD has been shown in numerous medical studies to have significant potential health benefits for a variety of ailments ranging from epilepsy to pain management.

Continue Reading

Hot Stock to WatchHot Stock to Watch

Pazoo Inc. (OTCQB: PZOO)

End of Day:

Price: 0.365

Change (%): - 0.0075 (2.01)

Volume: 1,516,312
PZOO Chart

Nutrition Zone To Carry Pazoo, Inc.'s CellMax Stem Cell Nutrition Concentrate

CEDAR KNOLLS, N.J., Sept. 20, 2012 /PRNewswire/ - Pazoo, Inc. (OTCBB Symbol: PZOO (German WKN#: A1J3DK)) is pleased to announce that New Jersey based Nutrition Zone will carry CellMax, the first in Pazoo's Max line of products. This now makes two retailers in as many days that have agreed to carry a Pazoo product line - one in the Health and Wellness industry and one in the pet industry. Pazoo is also in discussions several more retailers that may potentially come on line in the near future.

The CellMax product is an all natural life enhancement supplement that is a one of a kind scientifically formulated stem cell nutrition product that is patented and not duplicated anywhere else. The efficacy of the CellMax product is supported by numerous testimonials and scientific research. CellMax will be available for purchase under the Pazoo national brand very shortly. Final packaging and labeling is almost completed.

Continue Reading

Other Small Cap News

Company: GlobalWise Investments, Inc. (OTCBB: GWIV)

MissionIR Features GlobalWise in Exclusive Interview Featuring CEO William Santiago

ATLANTA, GA--(Marketwire - Sep 20, 2012) - MissionIR today announces that its interview with William J. "BJ" Santiago, the Chief Executive Officer of GlobalWise Investments, Inc. (OTCBB: GWIV), is now available online. The interview can be heard at

Mr. Santiago provided a brief overview of his background, the rapidly growing ECM industry, competitive advantages of GlobalWise's Intellivue™ software, and current expansion initiatives. He also discussed the company's advanced security technologies, multi-language support, and ability to seamlessly integrate its ECM solutions with outside software and hardware.

Continue Reading

Company: The Aristocrat Group Corp. (OTCBB: ASCC)

ASCC Receives Samples of Revolutionary Patented Biomolecule Skin Cream

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--The Aristocrat Group Corp. (OTCBB: ASCC) announced today that it received testing samples of a revolutionary new biomolecule face cream that could hold the key to younger-looking skin.

The miraculous new skin-care product was created by Regenetech, a biotech company with an exclusive license to expand - or multiply - adult stem cells using a NASA bioreactor technology developed for the space program. The active ingredients in the cream are biomolecules left behind after stem cell expansion, including cytokines, peptides and proteins capable of promoting healthy skin.

Continue Reading

Market News

By Pan Pylas: AP Business Writer

Market mood sours after downbeat economic news

LONDON (AP) -- The mood in financial markets turned sour Thursday after a round of disappointing economic news illustrated the scale of the global economic downturn.

Figures from Europe, Japan and China reminded investors that the world's economy is struggling, though a positive bond auction from Spain helped limit the retreat in markets.

Among the sobering news for investors was a survey in Europe pointing to a deepening recession in Europe, figures from Japan that showed the country's powerhouse export sector was continuing to suffer and a private survey of manufacturers in China that showed activity fell again in September, though at a slightly slower pace than August.

Continue Reading

By Claire Cain Miller:
The New York Times

Google to Topple Facebook as Leader in Display Ads, eMarketer Says

Google is set to overtake Facebook in earning money from display ads, making it the leader in all three types of digital advertising - search, mobile and display.

That is the prediction of eMarketer, a research firm that many in the tech industry rely on for its ad revenue forecasts. Earlier this year, it said that Facebook would maintain the lead, but this month cut its forecast for Facebook's revenue from display ads, which are ads with images or video.

Google is the latest company to shake up the industry in recent years. Yahoo was dominant in display advertising until last year, when Facebook overtook both Google and Yahoo.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks